疫苗市场规模预计将从2024年的804.5亿美元增至2031年的1189.4亿美元。预计2025年至2031年期间,疫苗市场的复合年增长率将达到5.7%。人工智能和大数据在疫苗研发中的融合正成为疫苗市场的一个重要趋势。
疫苗市场分析
由于新冠疫情 (COVID-19) 疫情后传染病激增以及公众意识的提升,疫苗市场正在经历大幅增长。世界各地的免疫接种项目已加强,以应对流感、人乳头瘤病毒 (HPV) 和肝炎等日益严重的疾病负担。技术创新,尤其是 mRNA、病毒载体、重组平台、人工智能驱动的抗原设计和先进的递送系统的出现,加速了研发管线的建设,并实现了快速、可扩展的开发。此外,政府资金和政策支持发挥着至关重要的作用:国家免疫计划、加速的监管途径以及 Gavi 和 COVAX 等公私合作伙伴关系正在降低门槛,扩大疫苗的可及性。新兴市场(尤其是亚太地区)的医疗保健投资不断增长,中产阶级的不断壮大和基础设施的不断改善正在推动疫苗的普及,这进一步增强了市场前景。这些因素共同推动了疫苗市场的持续扩张。
疫苗市场概况
全球疫苗市场正在加速扩张,这得益于流感、HPV、COVID-19 等传染病以及新兴病原体日益加重的负担,凸显了对预防性医疗保健解决方案的迫切需求。关键的市场驱动力包括疫苗技术的前沿创新,尤其是 mRNA、病毒载体、重组和基于纳米技术的平台,这些平台显著提高了开发速度和效力。推动市场增长的其他因素包括城市化和人口密度的提高、成人和老年人疫苗接种率的提高、以及简化免疫接种程序的联合疫苗的使用。此外,针对癌症和过敏等非传染性疾病的持续研发投入,正在扩大疫苗的范围和影响。
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
疫苗市场:

- 获取此报告的顶级关键市场趋势。此免费样品将包括数据分析,从市场趋势到估计和预测。
疫苗市场驱动因素和机遇
免疫接种计划和政府举措蓬勃发展,提振市场
免疫接种项目提供的服务旨在确保获得疫苗可预防疾病的免疫力。这些服务包括记录免疫证明、实施免疫接种和再次免疫,以及保存记录以便向州或地方免疫信息系统 (IIS)(也称为疫苗登记处)报告。
世卫组织于1974年制定了基本免疫规划(EPI),旨在通过国家免疫规划协调有针对性地实施疫苗接种。这一举措在扩大全球疫苗可及性方面发挥了重要作用。此外,全球疫苗和免疫联盟(Gavi)成立于2000年,是一个独立的多边筹资机制,旨在提高全球疫苗的可及性,在促进疫苗在中低收入国家(LMIC)的推广方面发挥了关键作用。根据2021年10月发表在《传染病杂志》上的一篇文章,据估计,疫苗接种已通过预防10种疫苗可预防疾病,在98个中低收入国家避免了至少3700万人死亡,这些疾病包括乙型流感嗜血杆菌、日本脑炎、A群脑膜炎奈瑟菌、麻疹、肺炎链球菌、轮状病毒、风疹和黄热病。
在各国及合作伙伴的支持下,世界卫生大会于2020年启动了一项名为“2030年免疫议程”的战略。该倡议旨在应对疫苗接种挑战,到2030年挽救超过5000万人的生命。在美国,疫苗接种计划多种多样,既包括像儿童疫苗接种计划这样的联邦项目,也包括州和地方的努力以及与各种组织的合作。由于这些项目旨在提高疫苗接种率,确保公平获得疫苗,并对抗可通过疫苗接种预防的疾病,疫苗市场持续以显著的速度增长。
开发联合疫苗和治疗性疫苗以创造增长机会
疫苗行业目前正经历转型阶段,联合疫苗和治疗性疫苗成为制造商最具前景的机遇。这些疫苗的创新不仅能够应对不断变化的公共卫生挑战,还能带来显著的商业和运营优势。
联合疫苗是一种旨在通过一次注射预防多种疾病的疫苗制剂。传统上,联合疫苗用于儿科护理,例如MMR(麻疹、腮腺炎、风疹)和DTP(白喉、破伤风、百日咳)等疫苗,如今正逐渐扩大其覆盖范围,覆盖成人和老年人群体。这对于流感、COVID-19和呼吸道合胞病毒(RSV)等呼吸道疾病尤为重要。联合疫苗可以显著提高免疫接种率,从而更快、更广泛地减轻疾病负担。在针对登革热、伤寒、呼吸道合胞病毒和结核病等疾病的新型疫苗研发过程中,联合疫苗尤为重要。据全球疫苗免疫联盟 (Gavi) 预测,到2030年,联合疫苗将能够以更少的剂量提供对30种感染的保护。
包括Moderna、辉瑞/BioNTech、诺瓦瓦克斯、赛诺菲、葛兰素史克和阿斯利康在内的大型制药公司正在开发针对新冠肺炎、流感和呼吸道合胞病毒(RSV)的联合疫苗。这些产品预计将改变季节性免疫策略,并提高成年人和老年人群的接种率。2025年6月,Moderna公司宣布,美国食品药品监督管理局(FDA)批准了该公司的RSV疫苗mRESVIA (mRNA-1345),用于预防18-59岁患病风险较高的人群中RSV引起的下呼吸道疾病(LRTD)。此次批准扩大了mRESVIA的先前适应症,该疫苗于2024年5月获批用于60岁及以上成年人。
此外,治疗性疫苗并非旨在预防疾病,而是治疗现有疾病,例如慢性感染、癌症和过敏。这种方法代表了疫苗技术的全新前沿,利用了mRNA、病毒载体和个性化医疗的进步。例如,癌症疫苗旨在刺激免疫系统识别并攻击肿瘤细胞。此外,一些针对乙肝和艾滋病毒等慢性感染的疫苗正在研发中。截至2024年,美国食品药品监督管理局 (FDA) 已批准三种治疗性疫苗:用于治疗晚期前列腺癌的Sipuleucel-T、用于治疗高危非肌层浸润性膀胱癌的卡介苗以及用于治疗黑色素瘤的Talimogene laherparepvec。因此,联合疫苗和治疗性疫苗的开发为疫苗制造商提供了巨大的发展、创新和产生重大影响的机会。这些疫苗简化了免疫接种,扩大了其应用范围,并满足了全球预防和治疗方面的健康需求。
疫苗市场报告细分分析
疫苗市场分析的基础关键部分是类型、适应症、给药途径和年龄组。
- 根据类型,疫苗市场分为结合疫苗、灭活疫苗、亚单位疫苗、减毒活疫苗、重组疫苗和类毒素疫苗。结合疫苗在2024年占据了最大的市场份额。
- 疫苗市场按适应症可分为HPV疫苗、PCV疫苗、DTP疫苗、肝炎疫苗、流感疫苗、登革热疫苗和其他疫苗。2024年,HPV疫苗占据了市场主导地位。
- 根据给药途径,市场分为注射、口服和其他。2024年,注射疫苗占据了疫苗市场份额的主导地位。
- 就年龄组而言,疫苗市场分为儿童疫苗和成人疫苗。2024年,儿童疫苗占据了市场主导地位。
疫苗市场份额按地区分析
疫苗市场报告的地理范围分为五个区域:北美、亚太、欧洲、中东和非洲以及南美和中美。
2024年,北美占据了相当大的市场份额。主要催化剂是传染病病例的增加,这导致了对包括疫苗在内的预防性医疗保健解决方案的持续需求。预防传染病的大规模免疫接种计划推动了大规模疫苗需求,因此,北美正在鼓励多项举措和战略来加强疫苗生产设施。此外,私营部门伙伴关系、国际合作以及政府和非政府组织的资金增加,也推动了新候选疫苗的研发。人们对旅行相关疫苗接种意识的提高,以及由于疫苗犹豫导致麻疹等可预防疾病的死灰复燃,也凸显了免疫接种的重要性,从而刺激了市场增长。
疫苗市场区域洞察
Insight Partners 的分析师已详尽阐述了预测期内影响疫苗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的疫苗市场细分和地域分布。

- 获取疫苗市场的区域特定数据
疫苗市场报告范围
报告属性 | 细节 |
---|---|
2024年的市场规模 | 804.5亿美元 |
2031年的市场规模 | 1189.4亿美元 |
全球复合年增长率(2025-2031) | 5.7% |
史料 | 2021-2023 |
预测期 | 2025-2031 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
疫苗市场参与者密度:了解其对商业动态的影响
疫苗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求的驱动因素包括消费者偏好的演变、技术进步以及对产品优势的认知度的提升。随着需求的增长,企业正在扩展产品线,不断创新以满足消费者需求,并抓住新兴趋势,从而进一步推动市场增长。
市场参与者密度是指特定市场或行业内企业或公司的分布情况。它表明特定市场空间内竞争对手(市场参与者)的数量相对于其规模或总市值而言。
在疫苗市场运营的主要公司有:
- 葛兰素史克公司
- 赛诺菲公司
- CSL Seqirus
- 雅培
- 印度血清研究所私人有限公司
- 科兴生物制品有限公司
免责声明:以上列出的公司没有按照任何特定顺序排列。

- 获取疫苗市场顶级关键参与者概览
疫苗市场新闻和最新发展
疫苗市场评估是通过收集一手和二手研究后的定性和定量数据进行的,这些数据包括重要的企业出版物、协会数据和数据库。市场的一个关键发展如下:
- 印度血清研究所 (Serum Institute of India) 是全球疫苗产量最大的生产商,该公司与 ImmunityBio, Inc. 达成了一项独家全球协议,将向 ImmunityBio 供应卡介苗 (BCG)。该协议涵盖生产已获准在美国以外地区使用的标准 BCG,以及目前正在测试的下一代重组 BCG (iBCG)。两家公司将合作加快正在欧洲进行的 iBCG 二期临床试验。(来源:印度血清研究所私人有限公司,新闻稿,2024 年 5 月)
- 葛兰素史克与加拿大政府就大流行性流感和季节性流感疫苗达成协议,旨在保护加拿大成人和儿童。该协议为期四年,有效期至2026年3月,包括在发生流感大流行时供应多达8000万剂Arepanrix(佐剂型大流行性流感疫苗),以及每年至少供应400万剂Flulaval Tetra(季节性流感疫苗)。(来源:葛兰素史克公司,新闻稿,2022年7月)
疫苗市场报告覆盖范围和交付成果
《疫苗市场规模和预测(2021-2031)》报告对以下领域进行了详细的市场分析:
- 疫苗市场规模以及涵盖范围内所有主要细分市场的全球、区域和国家层面的预测
- 疫苗市场趋势和市场动态,例如驱动因素、限制因素和关键机遇
- 详细的 PEST 和 SWOT 分析
- 疫苗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,包括市场集中度、热点图分析、知名参与者以及疫苗市场的最新发展
- 详细的公司简介
- 历史分析(2 年)、基准年、预测(7 年)及复合年增长率
- PEST 和 SWOT 分析
- 市场规模价值/数量 - 全球、区域、国家
- 行业和竞争格局
- Excel 数据集


- Hand Sanitizer Market
- Integrated Platform Management System Market
- Aesthetic Medical Devices Market
- Smart Locks Market
- Aircraft MRO Market
- Pharmacovigilance and Drug Safety Software Market
- Biopharmaceutical Contract Manufacturing Market
- Trade Promotion Management Software Market
- Wind Turbine Composites Market
- Toothpaste Market

Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
This text is related
to segments covered.

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
This text is related
to country scope.
常见问题
North America dominated the market in 2024.
The growing incidences of infectious diseases and disease outbreaks, and surging immunization programs and government initiatives contribute to market growth.
GlaxoSmithKline plc, Sanofi SA, CSL Seqirus, Abbott, Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd, Pfizer Inc., Mylan NV, Novartis, and Merck are among the key players operating in the vaccines market.
The market is expected to reach US$ 118.94 billion by 2031.
The market is estimated to register a CAGR of 5.7% during the forecast period.
The List of Companies - Vaccines Market
- GlaxoSmithKline plc
- Sanofi SA
- CSL Seqirus
- Abbott
- Serum Institute of India Pvt. Ltd.
- Sinovac Biotech Ltd
- Pfizer Inc
- Mylan NV
- Novartis
- Merck
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.